Getting inside the bug: new targets for TB drugs.
Sutherland
Stephani
S
sutherland@nasw.org
D000995:Antitubercular Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000472:pathogenicity; D011808:Quinone Reductases / Q000037:antagonists & inhibitors*; D014376:Tuberculosis / Q000517:prevention & control*
D000995:Antitubercular Agents; D004791:Enzyme Inhibitors; D011808:Quinone Reductases